The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment of stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: A report from Children’s Oncology Group study AREN0533.
David B. Dix
No relevant relationships to disclose
Eric J. Gratias
No relevant relationships to disclose
Nita Seibel
No relevant relationships to disclose
James Robert Anderson
No relevant relationships to disclose
Elizabeth Anne Mullen
No relevant relationships to disclose
James I. Geller
No relevant relationships to disclose
Geetika Khanna
No relevant relationships to disclose
John A. Kalapurakal
No relevant relationships to disclose
Elizabeth Jones Perlman
No relevant relationships to disclose
Peter F. Ehrlich
No relevant relationships to disclose
Marcio H. Malogolowkin
No relevant relationships to disclose
Paul Edward Grundy
No relevant relationships to disclose
Jeffrey Dome
No relevant relationships to disclose